Does anyone else wonder why they didn't extend the
Post# of 72440
Posted On: 11/09/2016 8:38:02 AM
Does anyone else wonder why they didn't extend the term of treatment in P2b? Make it 16 weeks? I guess one reason would be the ability to compare 12 weeks of data across 2a and 2b, but they could do that anyway. I wonder if the 200 mg dose effectiveness plateaued by 12 weeks?
Anyway, just thinking out loud.
Anyway, just thinking out loud.
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼